Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.
Adult
Asymptomatic Diseases
COVID-19
/ diagnosis
COVID-19 Nucleic Acid Testing
/ methods
COVID-19 Testing
/ statistics & numerical data
Egypt
/ epidemiology
Female
Fever
/ virology
Health Personnel
/ psychology
Hospitals, University
Humans
Infection Control
/ organization & administration
Male
Mass Screening
/ methods
Middle Aged
Pandemics
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
SARS-CoV-2
/ genetics
Tertiary Healthcare
/ organization & administration
COVID-19
Egypt
RT-PCR
SARS-CoV-2
asymptomatic
epidemiology
health care workers
resource-limited setting
screening
serology
Journal
International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871
Informations de publication
Date de publication:
03 03 2021
03 03 2021
Historique:
accepted:
11
08
2020
pubmed:
24
10
2020
medline:
12
3
2021
entrez:
23
10
2020
Statut:
ppublish
Résumé
The scale of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among health care workers (HCWs), particularly in resource-limited settings, remains unclear. To address this concern, universal (non-symptom-based) screening of HCWs was piloted to determine the proportion of SARS-CoV-2 infection and the associated epidemiological and clinical risk factors at a large public health care facility in Egypt. Baseline voluntary screening of 4040 HCWs took place between 22 April and 14 May 2020 at 12 hospitals and medical centres in Cairo. Epidemiological and clinical data were collected using an online survey. All participants were tested for SARS-CoV-2 using reverse transcription polymerase chain reaction (RT-PCR) and rapid IgM and IgG serological tests. Of the 4040 HCWs screened, 170 [4.2%; 95% confidence interval (CI): 3.6-4.9] tested positive for SARS-CoV-2 by either of the three tests (i.e. infected); 125/170 (73.5%) tested PCR-positive. Most infected HCWs were nurses (97/170, 57.5%). Median age of infected HCWs was 31.5 [interquartile range (IQR): 27.0-41.3] years. Of infected HCWs, 78 (45.9%) reported contact with a suspected case and 47 (27.6%) reported face-to-face contact within 2 m with a confirmed case. The proportion of infection among symptomatic HCWs (n = 54/616) was 8.8% (95% CI: 6.7-11.3); 6/54 (11.1%) had fever ≥38°C and 7/54 (13.0%) reported severe symptoms. Most infected HCWs were asymptomatic (116/170, 68.2%). The proportion of infection among asymptomatic HCWs (n = 116/3424) was 3.4% (95% CI: 2.8-4.0). The high rate of asymptomatic infections among HCWs reinforces the need for expanding universal regular testing. The infection rate among symptomatic HCWs in this study is comparable with the national rate detected through symptom-based testing. This suggests that infections among HCWs may reflect community rather than nosocomial transmission during the early phase of the COVID-19 epidemic in Egypt.
Sections du résumé
BACKGROUND
The scale of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among health care workers (HCWs), particularly in resource-limited settings, remains unclear. To address this concern, universal (non-symptom-based) screening of HCWs was piloted to determine the proportion of SARS-CoV-2 infection and the associated epidemiological and clinical risk factors at a large public health care facility in Egypt.
METHODS
Baseline voluntary screening of 4040 HCWs took place between 22 April and 14 May 2020 at 12 hospitals and medical centres in Cairo. Epidemiological and clinical data were collected using an online survey. All participants were tested for SARS-CoV-2 using reverse transcription polymerase chain reaction (RT-PCR) and rapid IgM and IgG serological tests.
RESULTS
Of the 4040 HCWs screened, 170 [4.2%; 95% confidence interval (CI): 3.6-4.9] tested positive for SARS-CoV-2 by either of the three tests (i.e. infected); 125/170 (73.5%) tested PCR-positive. Most infected HCWs were nurses (97/170, 57.5%). Median age of infected HCWs was 31.5 [interquartile range (IQR): 27.0-41.3] years. Of infected HCWs, 78 (45.9%) reported contact with a suspected case and 47 (27.6%) reported face-to-face contact within 2 m with a confirmed case. The proportion of infection among symptomatic HCWs (n = 54/616) was 8.8% (95% CI: 6.7-11.3); 6/54 (11.1%) had fever ≥38°C and 7/54 (13.0%) reported severe symptoms. Most infected HCWs were asymptomatic (116/170, 68.2%). The proportion of infection among asymptomatic HCWs (n = 116/3424) was 3.4% (95% CI: 2.8-4.0).
CONCLUSIONS
The high rate of asymptomatic infections among HCWs reinforces the need for expanding universal regular testing. The infection rate among symptomatic HCWs in this study is comparable with the national rate detected through symptom-based testing. This suggests that infections among HCWs may reflect community rather than nosocomial transmission during the early phase of the COVID-19 epidemic in Egypt.
Identifiants
pubmed: 33094320
pii: 5936053
doi: 10.1093/ije/dyaa173
pmc: PMC7665557
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-61Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2020; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2020 May 19;323(19):1912-1914
pubmed: 32221579
Mayo Clin Proc. 2020 Jun;95(6):1127-1129
pubmed: 32376102
J Clin Virol. 2020 Jul;128:104412
pubmed: 32416600
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Elife. 2020 May 11;9:
pubmed: 32392129
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Crit Care. 2020 Mar 27;24(1):120
pubmed: 32220243
Lancet Infect Dis. 2020 Sep;20(9):1034-1042
pubmed: 32422204
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
BMJ. 2020 Apr 2;369:m1375
pubmed: 32241884
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353